3 ms·
What if the effects are not based on one active compound, but on a complex mix which could be rather chaotic, but an experienced practitioner could devise a tre
by chii 11y ago
What if the effects are not based on one active compound, but on a complex mix which could be rather chaotic, but an experienced practitioner could devise a treatment, but a drug company can't easily pinpoint a one size fits all formulae?
- jszymborski 11y agoIt's inconceivable that an "experience practitioner" can devise a treatment a drug company can't manufacture, but you are correct that the economics of personlised medicines aren't financially viable for drug companies. I don't think there is a simple solution for that, but I can tell you is that these economics still won't prevent the discovery of such treatments. Some initial proof of this is the fact that the scientific community has embraced the concept that cancer is extremely heterogenous and will require a unique treatment for each individual patient (which has generated the "personalised medicine" buzzword).